Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-042023
Filing Date
2021-02-16
Accepted
2021-02-12 18:25:58
Documents
2
Group Members
COLUMN GROUP III GP, LPCOLUMN GROUP III-A, LPCOLUMN GROUP, LLCPONOI CAPITAL II, LPPONOI CAPITAL, LPPONOI II MANAGEMENT, LLCPONOI MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d122184dsc13g.htm SC 13G 156673
2 EX-99.1 d122184dex991.htm EX-99.1 12794
  Complete submission text file 0001193125-21-042023.txt   171217
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91387 | Film No.: 21630705
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP III, LP (Filed by) CIK: 0001668159 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G